Hence, it seems that in the case of SARS-CoV-2 infection in patients with coexisting disorders such as essential hypertension and CKD, physicians should consider, if it is possible, not prescribing AT1R blockers for the treatment of hypertension. Here, AGTR1 is linked to essential hypertension.